Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Chi

Showing results (11-20 of 410) with videos related to

Pageof 41
Sort By:
Journal of Clinical Epidemiology|May 17, 2000
The standard of reporting of health-related quality of life in clinical cancer trialsC W Lee, K N Chi
The Journal of Urology|August 13, 2003
Asian race and impact on outcomes after radical radiotherapy for localized prostate cancerAda Man, Tom Pickles, Kim N Chi, et al.
Genetics and Molecular Research : GMR|September 9, 2015
Amiloride, a urokinase-type plasminogen activator receptor (uTPA) inhibitor, reduces proteinurea in podocytesL B Xu, N Chi, W Shi
The Canadian Journal of Urology|December 26, 2006
Prednisone monotherapy in asymptomatic hormone refractory prostate cancerDaniel Y C Heng, Kim N Chi
Angewandte Chemie (International Ed. in English)|January 30, 2016
Enzyme Selectivity Fine-Tuned through Dynamic Control of a LoopBeat Vögeli, Stefan Bibow, Celestine N Chi
Pediatric Blood & Cancer|August 25, 2016
Pediatric malignant germ cell tumors: A comparison of the neuro-oncology and solid tumor experienceAshley S Plant, Susan N Chi, Lindsay Frazier
Expert Opinion on Investigational Drugs|November 18, 2008
Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin for the treatment of cancerKim N Chi, Amina Zoubeidi, Martin E Gleave
Cryo Letters|March 16, 2025
Cloning, expression, purification and enzymatic characterization of low-temperature cholesterol esterase from marine Panthenia agglutinosaZ Wei, X Chi, N Chi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivoH Miyake, K N Chi, M E Gleave
Prostate Cancer and Prostatic Diseases|January 16, 2021
Clinical implications of genomic alterations in metastatic prostate cancerTakayuki Sumiyoshi, Kim N Chi, Alexander W Wyatt
Pageof 41

Showing results (11-20 of 410) with videos related to

Sort By:
Pageof 41
Journal of Clinical Epidemiology|May 17, 2000
The standard of reporting of health-related quality of life in clinical cancer trialsC W Lee, K N Chi
The Journal of Urology|August 13, 2003
Asian race and impact on outcomes after radical radiotherapy for localized prostate cancerAda Man, Tom Pickles, Kim N Chi, et al.
Genetics and Molecular Research : GMR|September 9, 2015
Amiloride, a urokinase-type plasminogen activator receptor (uTPA) inhibitor, reduces proteinurea in podocytesL B Xu, N Chi, W Shi
The Canadian Journal of Urology|December 26, 2006
Prednisone monotherapy in asymptomatic hormone refractory prostate cancerDaniel Y C Heng, Kim N Chi
Angewandte Chemie (International Ed. in English)|January 30, 2016
Enzyme Selectivity Fine-Tuned through Dynamic Control of a LoopBeat Vögeli, Stefan Bibow, Celestine N Chi
Pediatric Blood & Cancer|August 25, 2016
Pediatric malignant germ cell tumors: A comparison of the neuro-oncology and solid tumor experienceAshley S Plant, Susan N Chi, Lindsay Frazier
Expert Opinion on Investigational Drugs|November 18, 2008
Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin for the treatment of cancerKim N Chi, Amina Zoubeidi, Martin E Gleave
Cryo Letters|March 16, 2025
Cloning, expression, purification and enzymatic characterization of low-temperature cholesterol esterase from marine Panthenia agglutinosaZ Wei, X Chi, N Chi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivoH Miyake, K N Chi, M E Gleave
Prostate Cancer and Prostatic Diseases|January 16, 2021
Clinical implications of genomic alterations in metastatic prostate cancerTakayuki Sumiyoshi, Kim N Chi, Alexander W Wyatt
Pageof 41